Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Which Are those Included in Neurology Data Sources

Dhondt Ortibus

The field of neurology relies heavily on a wealth of data sources to advance our understanding of the intricate workings of the nervous system, diagnose disorders, and develop effective treatments. This abstract delves into the diverse range of data sources that contribute to the expansive landscape of neurology research and clinical practice. It highlights the critical role played by these sources in shaping the future of neurology and enhancing patient care. Neurology, as a multifaceted discipline, demands a robust foundation of data for both research and clinical purposes. Neurologists and researchers draw insights from a wide array of data sources, encompassing clinical records, neuroimaging, genetics, and wearable devices, among others. This investigation delves into the comprehensive spectrum of neurology data sources, shedding light on their individual contributions and their interconnectedness. Clinical data sources, such as electronic health records (EHRs), offer a treasure trove of patient information, facilitating accurate diagnosis and treatment planning. Neuroimaging data, including MRI, CT scans, and PET scans, provide invaluable glimpses into the brain’s structure and function, aiding in the identification of neurological conditions. Genomic data sources, in the form of large-scale genetic studies and biobanks, have revolutionized our understanding of the genetic underpinnings of neurological diseases. Moreover, wearable devices and patient-reported data play an increasingly prominent role in monitoring disease progression and treatment efficacy.